2017 Imprinting of Pharmaceuticals
Authors:
Munawar Hussain*, Hans P Wendel and Frank K Gehring
Journal:
Int J Pharma Anal Acta. 2017;1(1): 013-014., 20 January, 2020
Institut:
Biosensor Research Group, Thoracic, Cardiac and Vascular Surgery Department, Tuebingen University, Germany
*Address for Correspondence:Biosensor Research Group, Thoracic, Cardiac and Vascular Surgery Department, Tuebingen University, Germany,
Abstract:
Molecular imprinting technology is promising for pharmaceutical applications for instance, separation, extraction, quantitative analysis, qualitative analysis, screening, delivery and targeting of medicines or their metabolites. Th e literature demonstrates similar or sometimes even higher selectivity on comparing with those of natural antibodies. Achieving selectivity is still challenging [1], because natural antibodies are generated in nature via “induced fi t” mechanism along with the natural optimization of the analyte-receptor interaction [2].